Screener
Eligibility screening
OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
4 US sites in TX, VA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
4 US sites in TX, VA
Before we begin
Your answer affects how the questions are phrased.